Dare Bioscience (DARE) Short Interest Ratio & Short Volume $2.03 +0.01 (+0.50%) Closing price 04:00 PM EasternExtended Trading$2.02 -0.01 (-0.44%) As of 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Dare Bioscience Short Interest DataDare Bioscience (DARE) has a short interest of 261,100 shares, representing 1.97% of the float (the number of shares available for trading by the public). This marks a 13.67% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 218,074 shares to cover all short positions.Current Short Interest261,100 sharesPrevious Short Interest229,700 sharesChange Vs. Previous Month+13.67%Dollar Volume Sold Short$574.42 thousandShort Interest Ratio0.2 Days to CoverLast Record DateAugust 15, 2025Outstanding Shares13,480,000 sharesFloat Size13,260,000 sharesShort Percent of Float1.97%Today's Trading Volume79,016 sharesAverage Trading Volume218,074 sharesToday's Volume Vs. Average36% Short Selling Dare Bioscience? Sign up to receive the latest short interest report for Dare Bioscience and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartDARE Short Interest Over TimeDARE Days to Cover Over TimeDARE Percentage of Float Shorted Over Time Dare Bioscience Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 8/15/2025261,100 shares $574.42 thousand +13.7%2.0%0.2 $2.20 7/31/2025229,700 shares $551.28 thousand -79.3%2.6%0.2 $2.40 7/15/20251,110,000 shares $3.15 million +2,276.9%12.7%0.8 $2.84 6/30/202546,700 shares $111.61 thousand +1.5%0.5%1.8 $2.39 6/15/202546,000 shares $139.38 thousand -30.4%0.5%2 $3.03 5/31/202566,100 shares $189.71 thousand +8.7%0.8%3.4 $2.87 5/15/202560,800 shares $175.10 thousand +13.2%0.7%3 $2.88 4/30/202553,700 shares $158.42 thousand +13.3%0.6%2.7 $2.95 4/15/202547,400 shares $139.83 thousand -24.0%0.5%2.1 $2.95 3/31/202562,400 shares $180.34 thousand -28.6%0.7%2.6 $2.89 Get the Latest News and Ratings for DARE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Dare Bioscience and its competitors with MarketBeat's FREE daily newsletter. 3/15/202587,400 shares $251.71 thousand +22.2%1.0%3.1 $2.88 2/28/202571,500 shares $224.51 thousand -21.5%0.8%2 $3.14 2/15/202591,100 shares $276.94 thousand +4.0%1.1%2.4 $3.04 1/31/202587,600 shares $284.70 thousand -4.3%1.0%2 $3.25 1/15/202591,500 shares $304.70 thousand +5.7%1.1%1.9 $3.33 12/31/202486,600 shares $270.19 thousand +50.9%1.0%1.7 $3.12 12/15/202457,400 shares $182.53 thousand +2.9%0.7%1.1 $3.18 11/30/202455,800 shares $190.84 thousand +118.8%0.7%1.4 $3.42 11/15/202425,500 shares $81.86 thousand -13.3%0.3%0.6 $3.21 10/31/202429,400 shares $124.36 thousand -33.9%0.4%0.7 $4.23 10/15/202444,500 shares $156.20 thousand +14.7%0.5%1.2 $3.51 9/30/202438,800 shares $125.71 thousand +9.6%0.5%1 $3.24 9/15/202435,400 shares $117.17 thousand -9.7%0.4%0.8 $3.31 8/31/202439,200 shares $140.34 thousand +19.9%0.5%0.8 $3.58 8/15/202432,700 shares $113.80 thousand +51.4%0.4%0.7 $3.48 7/31/202421,600 shares $74.09 thousand -63.3%0.3%0.5 $3.43 7/15/202458,900 shares $198.49 thousand +68.3%0.7%0.9 $3.37 6/30/202435,000 shares $141.16 thousand -79.8%0.4%0.5 $4.03 6/15/2024172,900 shares $77.77 thousand -71.2%N/A0.3 $0.45 5/31/2024600,200 shares $246.08 thousand +12.6%N/A0.9 $0.41 5/15/2024532,900 shares $191.84 thousand +83.6%N/A0.7 $0.36 4/30/2024290,300 shares $89.27 thousand +17.6%N/A0.4 $0.31 4/15/2024246,900 shares $118.54 thousand +5.1%N/A0.6 $0.48 3/31/2024235,000 shares $115.20 thousand -48.5%N/A0.6 $0.49 3/15/2024456,200 shares $213.68 thousand -14.0%N/A1.1 $0.47 2/29/2024530,500 shares $304.51 thousand +5.2%N/A0.8 $0.57 2/15/2024504,200 shares $184.39 thousand -10.1%N/A0.8 $0.37 1/31/2024560,900 shares $182.29 thousand -11.3%N/A1 $0.33 1/15/2024632,000 shares $229.80 thousand -27.3%N/A1.1 $0.36 12/31/2023869,800 shares $268.77 thousand -11.2%N/A1.6 $0.31REVEALED FREE: Our top 3 stocks to own in 2025 and beyond (Ad)Every time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (including the losers!). Click here for the names of our three top stocks to own this year (no purchase necessary). 12/15/2023979,200 shares $344.58 thousand +76.8%N/A2 $0.35 11/30/2023553,900 shares $193.87 thousand +23.9%N/A1.3 $0.35 11/15/2023447,000 shares $152.96 thousand -22.6%N/A1.8 $0.34 10/31/2023577,300 shares $247.08 thousand +0.9%N/A2.5 $0.43 10/15/2023572,300 shares $263.26 thousand -4.7%N/A2.4 $0.46 9/30/2023600,300 shares $277.22 thousand +4.8%N/A2.2 $0.46 9/15/2023572,800 shares $292.13 thousand -31.6%N/A1.9 $0.51 8/31/2023836,800 shares $572.62 thousand +19.4%N/A2.7 $0.68 8/15/2023700,900 shares $515.09 thousand +11.6%N/A2.4 $0.73 7/31/2023628,300 shares $469.15 thousand -9.3%N/A2.2 $0.75 7/15/2023692,400 shares $602.39 thousand +45.1%N/A2.6 $0.87 6/30/2023477,100 shares $434.21 thousand +29.4%N/A2.2 $0.91 6/15/2023368,600 shares $353.86 thousand +7.6%N/A1.9 $0.96 5/31/2023342,600 shares $346.03 thousand -9.5%N/A1.8 $1.01 5/15/2023378,600 shares $382.39 thousand -25.9%N/A2 $1.01 4/30/2023511,000 shares $511 thousand -16.6%N/A2.5 $1.00 4/15/2023612,400 shares $618.52 thousand +12.5%N/A2.2 $1.01 3/31/2023544,400 shares $566.18 thousand +16.8%N/A1.8 $1.04 3/15/2023466,000 shares $466 thousand -15.9%N/A1.5 $1.00 2/28/2023554,100 shares $576.26 thousand -49.6%N/A1.8 $1.04 2/15/20231,100,000 shares $1.24 million -38.6%N/A3.5 $1.13 1/31/20231,790,000 shares $2.27 million +51.7%N/A5.7 $1.27 1/15/20231,180,000 shares $1.42 million -13.2%N/A5.1 $1.20 12/30/20221,360,000 shares $1.13 million +33.3%N/A5.7 $0.83 12/15/20221,020,000 shares $922.08 thousand -12.8%N/A4.1 $0.90 11/30/20221,170,000 shares $1.04 million +4.5%N/A4.5 $0.89 11/15/20221,120,000 shares $1.06 million -0.9%N/A4.1 $0.95 10/31/20221,130,000 shares $1.10 million -8.1%N/A3.8 $0.97 10/15/20221,230,000 shares $1.10 million -12.1%N/A3.7 $0.89 9/30/20221,400,000 shares $1.40 million -0.7%N/A3.6 $1.00 9/15/20221,410,000 shares $1.55 million -3.4%N/A2.2 $1.10 8/31/20221,460,000 shares $1.58 million -2.7%N/A2 $1.08 8/15/20221,500,000 shares $1.89 million +2.7%N/A1.8 $1.26 7/31/20221,460,000 shares $1.62 million -0.7%N/A1.6 $1.11 7/15/20221,470,000 shares $1.81 million -24.6%N/A1.4 $1.23 6/30/20221,950,000 shares $2.40 million +18.9%N/A1.7 $1.23 6/15/20221,640,000 shares $2.00 million -15.9%N/A1.2 $1.22 5/31/20221,950,000 shares $2.40 million -14.5%N/A1.4 $1.23 5/15/20222,280,000 shares $2.39 million -1.7%N/A1.6 $1.05 4/30/20222,320,000 shares $2.62 million +10.0%N/A1.5 $1.13 4/15/20222,110,000 shares $2.89 million +1.0%N/A1.2 $1.37 3/31/20222,090,000 shares $3.11 million -2.8%N/A1 $1.49 3/15/20222,150,000 shares $3.14 million -8.9%N/A0.9 $1.46 2/28/20222,360,000 shares $3.52 million +7.8%N/A0.4 $1.49 2/15/20222,190,000 shares $3.48 million -17.7%N/A0.4 $1.59 1/31/20222,660,000 shares $4.18 million -22.7%N/A0.5 $1.57 1/15/20223,440,000 shares $5.71 million -6.0%N/A0 $1.66 12/31/20213,660,000 shares $7.32 million -39.6%N/A0.7 $2.00 12/15/20216,060,000 shares $11.15 million +227.6%N/A1.1 $1.84 11/30/20211,850,000 shares $3.33 million +4.5%N/A0.4 $1.80REVEALED FREE: Our top 3 stocks to own in 2025 and beyond (Ad)Every time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (including the losers!). Click here for the names of our three top stocks to own this year (no purchase necessary). 11/15/20211,770,000 shares $3.06 million -22.4%N/A0.8 $1.73 10/29/20212,280,000 shares $3.33 million +72.7%N/A0.8 $1.46 10/15/20211,320,000 shares $2.07 million -20.5%N/A0.4 $1.57 9/30/20211,660,000 shares $2.77 million -48.0%N/A0.4 $1.67 9/15/20213,190,000 shares $5.33 million -31.3%N/A0.3 $1.67 8/31/20214,640,000 shares $8.12 million -3.1%N/A0.5 $1.75 8/13/20214,790,000 shares $7.66 million +8.9%N/A0.5 $1.60 7/30/20214,400,000 shares $6.78 million -16.2%9.5%0.5 $1.54 7/15/20215,250,000 shares $8.45 million +126.3%11.4%0.7 $1.61 6/30/20212,320,000 shares $4.38 million +82.7%5.0%0.3 $1.89 6/15/20211,270,000 shares $1.70 million -0.8%2.8%1.6 $1.34 5/28/20211,280,000 shares $1.64 million -1.5%2.8%1.6 $1.28 5/14/20211,300,000 shares $1.61 million +12.1%N/A1.4 $1.24 4/30/20211,160,000 shares $1.75 million +0.9%N/A1 $1.51 4/15/20211,150,000 shares $1.73 million -6.5%N/A0 $1.50 3/31/20211,230,000 shares $2.03 million +1.7%N/A0.4 $1.65 3/15/20211,210,000 shares $2.69 million +0.8%N/A0.4 $2.22 2/26/20211,200,000 shares $2.32 million -16.1%N/A0.4 $1.93 2/12/20211,430,000 shares $3.42 million +10.9%N/A0.5 $2.39 1/29/20211,290,000 shares $2.79 million +126.5%N/A0.4 $2.16 1/15/2021569,500 shares $877.03 thousand -22.9%N/A0.2 $1.54 12/31/2020738,400 shares $967.30 thousand +41.3%N/A0.7 $1.31 12/15/2020522,600 shares $600.99 thousand +51.1%N/A0.5 $1.15 11/30/2020345,900 shares $466.97 thousand +44.8%N/A0.4 $1.35 11/15/2020238,900 shares $258.01 thousand -4.6%N/A0.4 $1.08 10/30/2020250,400 shares $245.39 thousand +296.8%N/A0.5 $0.98 10/15/202063,100 shares $67.52 thousand -45.2%N/A0.1 $1.07 9/30/2020115,200 shares $115.05 thousand -38.3%N/A0.1 $1.00 9/15/2020186,600 shares $207.13 thousand +15.3%N/A0.2 $1.11 DARE Short Interest - Frequently Asked Questions What is Dare Bioscience's current short interest? Short interest is the volume of Dare Bioscience shares that have been sold short but have not yet been covered or closed out. As of August 15th, traders have sold 261,100 shares of DARE short. 1.97% of Dare Bioscience's shares are currently sold short. Learn More on Dare Bioscience's current short interest. What is a good short interest percentage for Dare Bioscience? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.97% of Dare Bioscience's floating shares are currently sold short. Is Dare Bioscience's short interest increasing or decreasing? Dare Bioscience saw a increase in short interest in the month of August. As of August 15th, there was short interest totaling 261,100 shares, an increase of 13.7% from the previous total of 229,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Dare Bioscience's float size? Dare Bioscience currently has issued a total of 13,480,000 shares. Some of Dare Bioscience's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Dare Bioscience currently has a public float of 13,260,000 shares. How does Dare Bioscience's short interest compare to its competitors? 1.97% of Dare Bioscience's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Dare Bioscience: Equillium, Inc. (5.51%), Adagene Inc. Sponsored ADR (0.05%), Biomea Fusion, Inc. (16.74%), Anebulo Pharmaceuticals, Inc. (1.70%), MacroGenics, Inc. (6.72%), Cassava Sciences, Inc. (12.92%), TScan Therapeutics, Inc. (4.01%), Alto Neuroscience, Inc. (8.28%), Spero Therapeutics, Inc. (1.65%), HilleVax, Inc. (1.06%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Lucid Group, Inc. ($8.00 billion), Spotify Technology ($5.48 billion), AppLovin Corporation ($5.11 billion), Reddit Inc. ($5.02 billion), Coinbase Global, Inc. ($3.99 billion), Charter Communications, Inc. ($3.89 billion), Live Nation Entertainment, Inc. ($3.18 billion), Seagate Technology Holdings PLC ($2.59 billion), ResMed Inc. ($2.55 billion), and Rocket Lab Corporation ($2.52 billion). View all of the most shorted stocks. What does it mean to sell short Dare Bioscience stock? Short selling DARE is an investing strategy that aims to generate trading profit from Dare Bioscience as its price is falling. DARE shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Dare Bioscience? A short squeeze for Dare Bioscience occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of DARE, which in turn drives the price of the stock up even further. How often is Dare Bioscience's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DARE, twice per month. The most recent reporting period available is August, 15 2025. More Short Interest Resources from MarketBeat Related Companies EQ Short Squeeze ADAG Short Squeeze BMEA Short Squeeze ANEB Short Squeeze MGNX Short Squeeze SAVA Short Squeeze TCRX Short Squeeze ANRO Short Squeeze SPRO Short Squeeze HLVX Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:DARE) was last updated on 9/2/2025 by MarketBeat.com Staff From Our Partners2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredDid you spot this in the Oval Office last week?When Tim Cook stood in the Oval Office last week, all eyes were on the "unique 24K gold gift" he presented to ...InvestorPlace | SponsoredWall Street Legend Names #1 ‘Hidden’ AI Stock50-year Wall Street legend says to forget NVDA. For the biggest potential gains, it's time to move your money ...Chaikin Analytics | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dare Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Dare Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DARE Stock Alerts